› › Sorrento Therapeutics

Sorrento Therapeutics News - SRNE

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Sorrento Therapeutics Inc SRNE NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.06 -3.21% 1.81 1.75 1.89 1.87 1.87 00:00:00
more quote information »

Recent News

Date Time Source Heading
3/25/202010:00GLOBESorrento Launches Novel I-Cell™ COVID-19 Cellular Vaccine..
3/24/202017:02EDGARUnknown (sec Staff)
3/24/202016:12EDGARUnknown (sec Staff)
3/24/202009:32GLOBESORRENTO COLLABORATES WITH MABPHARM ON DEVELOPMENT AND..
3/23/202009:00GLOBESORRENTO AND SMARTPHARM TO COLLABORATE TO DEVELOP NOVEL..
3/23/202006:01EDGARNotice of Effectiveness (effect)
3/20/202007:01EDGARCurrent Report Filing (8-k)
3/20/202007:00GLOBESORRENTO DEVELOPS STI-4398 (COVIDTRAP™ PROTEIN) FOR..
3/13/202006:01EDGARSecurities Registration Statement (simplified Form) (s-3)
3/06/202016:42EDGARCurrent Report Filing (8-k)
3/05/202013:59EDGARStatement of Changes in Beneficial Ownership (4)
3/03/202006:09EDGARAnnual Report (10-k)
2/27/202015:30GLOBESorrento Therapeutics Presents Interim Positive Results of..
2/27/202006:19EDGARCurrent Report Filing (8-k)
2/27/202006:00GLOBESorrento to Provide Corporate Update, Including DAR-T Cell..
2/21/202010:48EDGARUnknown (sec Staff)
2/21/202010:47EDGARUnknown (sec Staff)
2/21/202009:15GLOBESorrento Therapeutics CEO Dr. Ji to Present at LEERINK..
2/14/202006:14EDGARAmended Statement of Ownership (sc 13g/a)
2/12/202017:04EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/11/202006:03EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
2/11/202006:03EDGARCurrent Report Filing (8-k)
2/10/202016:48EDGARAmended Statement of Ownership (sc 13g/a)
2/10/202016:47EDGARAmended Statement of Ownership (sc 13g/a)
2/10/202016:46EDGARAmended Statement of Ownership (sc 13g/a)
2/06/202009:11EDGARAmended Statement of Ownership (sc 13g/a)
1/30/202006:01EDGARNotice of Effectiveness (effect)
1/29/202016:46EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
1/29/202007:00GLOBESorrento and Celularity to Initiate Emergency Allogeneic..
1/27/202007:01EDGARCurrent Report Filing (8-k)
1/27/202007:00GLOBESorrento Board Rejects Latest Acquisition Proposal
1/24/202016:41EDGARSecurities Registration Statement (simplified Form) (s-3/a)
1/24/202006:04EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
1/24/202006:00EDGARNotice of Effectiveness (effect)
1/23/202006:02EDGARSecurities Registration Statement (simplified Form) (s-3/a)
1/17/202017:09EDGARSecurities Registration Statement (simplified Form) (s-3)
1/17/202016:18EDGARSecurities Registration Statement (simplified Form) (s-3/a)
1/10/202007:01EDGARCurrent Report Filing (8-k)
1/10/202007:00GLOBESorrento Therapeutics, Inc. Received Non-Binding Acquisition..
1/07/202017:02EDGARSecurities Registration Statement (simplified Form) (s-3/a)
1/06/202007:00GLOBESorrento Announces Filing for Approval of Infliximab..
12/20/201916:16EDGARCurrent Report Filing (8-k)
12/18/201917:57EDGARStatement of Changes in Beneficial Ownership (4)
12/18/201917:52EDGARInitial Statement of Beneficial Ownership (3)
12/17/201917:26EDGARSecurities Registration Statement (simplified Form) (s-3/a)
12/16/201907:00GLOBESorrento Announces Dr. Robin Smith as New Member of the..
12/11/201917:09EDGARStatement of Changes in Beneficial Ownership (4)
12/11/201917:07EDGARInitial Statement of Beneficial Ownership (3)
12/09/201907:01EDGARCurrent Report Filing (8-k)
12/09/201907:00GLOBESorrento Announces New Board Member
See more news about this stock »
Your Recent History
NASDAQ
SRNE
Sorrento T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200328 15:02:48